Work

Op0115 Effect of Nintedanib on Progression of Interstitial Lung Disease (ild) in Patients With Autoimmune Disease-related Ilds: Further Data From the Inbuild Trial

Year: 2020

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2020-eular.3211

Authors: E. Matteson, C. Kelly, J. Distler, A.M. Hoffmann-Vold, J. Seibold, S. Mittoo, O. Distler, P.F. Dellaripa, A. James, R. Schlenker-Herceg, S. Stowasser, M. Quaresma, K.R. Flaherty

Institutions: Mayo Clinic, Newcastle University, Friedrich-Alexander-Universität Erlangen-Nürnberg, Oslo University Hospital, University Health Network, University Hospital Zurich, Brigham and Women's Hospital, Boehringer Ingelheim (Germany), Boehringer Ingelheim (United States), University of Michigan, Michigan Medicine

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3038884590

Cites:

Cited by: 6

Related to: 10